Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 1, 2004, Pages 205-208

  Doggrell, Sheila A ^a  

^a Doggrell Biomedical Communications   (New Zealand)

Author keywords

Carvedilol; Heart failure; Metoprolol

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL TARTRATE; NITRATE; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; EUROPE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SIDE EFFECT; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; PROPANOLAMINES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0346656617     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.1.205     Document Type: Article

References (15)

1. POOLE-WILSON PA. SWEDBERG K, CLELAND JGF et al.: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET); randomised controlled trial. Lancet (2003) 362:7-13.
2. STEWART S, MACINTYRE & HOLE DJ, CAPEWELL S, MCMURRAY JJV: More 'malignant' than cancer? Five-year survival following a fast admission for heart failure Eur. J. Heart Fail. (2001) 3:315-322.
3. PACKER M, BRISTOW MR, COHN JN et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N. Engl. J. Med (1996) 334:1349-1355.
4. PACKER M, COATS AJ, FOWLER MR et al.: Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med. (2001) 344:1651-1658.
5. WAAGSTEIN R, BRISTOW MR. SWEDBERG K et al.: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet (1993) 342:1441-1446.
6. THE MERIT-HF INVESTIGATORS: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet (1999) 353:2001-2007.
7. GOLDSTEIN S, FAGERBERG B, HJAALMARSON A et al.: Metoprolol controlled release/extended release in patients with severe heart failure. J. Am. Coll. Cardiol. (2001) 38:932-938.
8. GILBERT EM, ABRAHAM WT, OLSEN S et al.: Comparative hemodynamic, left ventricular functional, and anti-adrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation (1996) 94:2817-2825.
9. SANDERSON JE, CHAN SK, YIP G et al.: Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. J. Am Coll. Cardiol. (1999) 34:1522-1528.
10. METRA M, GIUBBINI R, NODARI S et al.: Differential effects of β-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation (2000) 102:546-551.
11. DI LENARDA A, SABBADINI G, SALVATORE L et al.: Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. J. Am. Coll Cardiol. (1999) 33:1926-1934.
12. THE INTERNATIONAL STEERING COMMITTEE: Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). Am. J. Cardiol. (1997) 80:54J-58J.
13. WIKSTRAND, J, HJALMARSON A. WAAGSTEIN F et al.: Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). J. Am. Coll. Cardiol. (2002) 7.491-498.
14. DARGIE HJ: Beta blockers in heart failure. Lancet (2003) 362:2-3.
15. SANDBERG A, BLOMQVIST I, JONSSON UE, LUNDBORG, P: Parmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets. Eur. J. Clin. Pharmacol. (1988) 33(Suppl.):S9-S14.